MedPath

Effect of pre-operative pain treatment by means of duloxetine on postoperative outcome after total hip or knee arthroplasty- The DOA study

Conditions
osteoarthritis
central sensitization
peripheral sensitization
residual painDutch: artrose
centrale sensitisatie
perifere sensitisatie
residuele pijn
Registration Number
NL-OMON25835
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
118
Inclusion Criteria

Primary hip or knee osteoarthitis, age above 18 years and a neuropathic pain profile

Exclusion Criteria

Surgical hip or knee procedure in previous year, hip or knee arthroscopy or injection past 3 months, unstable other medical condition, cognitive of neurological disorder or peripheral nerve injury, previous exposure to duloxetine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Degree of pain relief 6 months after total hip or knee arthroplasty
Secondary Outcome Measures
NameTimeMethod
Degree of pain relief at other timepoints, specific neuropathic pain symptoms, functional improvement, physical activity, anxiety and depressive symptoms, quality of life and pain catastrophizing
© Copyright 2025. All Rights Reserved by MedPath